Literature DB >> 35846913

A novel UBE2A splice site variant causing intellectual disability type Nascimento.

Shuyuan Yan1, Yanling Wang1, Ying Chen1, Hongxia Yuan1, Xiaoni Kuang1, Da Hou1, Xueyi Li1, Linglin Pan1, Guangwen Huang2, Jun He1, Tuanmei Wang1, Xiangwen Peng1.   

Abstract

X-linked intellectual disability type Nascimento (XLID) is a rare disease caused by variants in the ubiquitin-conjugating enzyme E2A gene (UBE2A). Patients with XLID have similar phenotypes, including speech impairments, severe intellectual disability, hearing loss, wide facies, synophrys, generalized hirsutism, and urogenital abnormalities. Till date, only two splice-site variants of the UBE2A gene have been observed in patients with X-linked ID type Nascimento. Here, we report the case of a Chinese boy with a syndrome clinically similar to XLID with speech impairment, severe intellectual disability, and moderate hearing loss. However, different characteristics were also present in the patient, including an inability to maintain his head in an upright posture. Both of the patient's palms have a single transverse palmar crease. Subsequent whole-exome sequencing revealed a novel splice site variant in UBE2A (c.241 + 1 G > A). Our study not only expands the variant spectrum and clinical characteristics of UBE2A deficiency syndrome but also provides clinical evidence for genetic diagnoses.
© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Entities:  

Keywords:  UBE2A splice site mutation (c.241 + 1 G > a); X‐linked intellectual disability type Nascimento

Year:  2022        PMID: 35846913      PMCID: PMC9272217          DOI: 10.1002/ccr3.5990

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


INTRODUCTION

X‐linked ID type Nascimento (XLID), characterized by a syndromic intellectual disability due to gene variants on the X chromosome, has received great attention due to the high incidence rate of intellectual disability in males. , , , , According to recent reports, the X‐chromosome comprises only approximately 5% of the human genome but accounts for approximately 15% of the genes currently known to be associated with intellectual disability. Ubiquitin‐conjugating enzyme E2 (UBE2A) is involved in the proteasome pathway for protein degradation and DNA repair and is located on Xq24. , , UBE2A contains 6 exons, and the protein contains 119 amino acids. UBE2A deficiency syndrome, also known as X‐linked ID type Nascimento (MIM #300860), was first described by Nascimento in 2006 and was characterized clinically by a pronounced delay in psychomotor development, wide facies, synophrys, generalized hirsutism, a horizontal eyebrow, and urogenital abnormalities. , Since then, two splice‐site variants in UBE2A, seven missense variants in UBE2A, and four larger deletions in UBE2A have been found. , However, there have been few reports of UBE2A splice site variants in China. Here, we report the case of a Chinese patient diagnosed with XLID with a novel UBE2A splice site mutation (c.241 + 1 G > A) with a few unique clinical features. Identifying novel variants of UBE2A in XLID will help prevent disability and provide more opportunities to explore the molecular basis of intellectual disability.

Ethics compliance

Written informed consent was obtained from the patient's parents, and all of the procedures were reviewed and approved by the Ethics Committee of Changsha Hospital for Maternal and Child Health Care at Hunan Normal University (Hunan, Changsha, China).

CASE PRESENTATION

The proband was born on September 18, 2018; a boy, G1P1, 35 weeks 4 days gestation, birthed by cesarean section due to fetal distress, with a birth weight of 2.15 kg, and an unknown Apgar score. A history of intrapartum hypoxia or asphyxia was denied. At a gestational age of 34 weeks and 4 days, Doppler ultrasound showed that the femur and humerus were at a size expected for approximately 30 weeks of gestational age, the internal diameter of the fetal aortic arch and isthmus was slightly narrow, the umbilical vein was abnormal, the S/D ratio of the umbilical vein was higher than the RI value, and the S/D and RI values of the middle cerebral artery were lower. Neither numerical nor gross structural chromosomal abnormalities were found (Figure 1). A SNP (Affymetrix CytoScan 750 K Array) gene chip analysis revealed no pathogenic microdeletion or microduplication aberrations in the whole genome.
FIGURE 1

Karyotype analysis showed no abnormalities

Karyotype analysis showed no abnormalities On September 18, 2018, the patient was hospitalized for 28 days for neonatal treatment at the Second Affiliated Hospital of Xiangya as a result of “premature birth and intrauterine distress” (the specific diagnoses and treatments administered are unknown). The patient remained unable to maintain his head in an upright posture from 7+ months to 40 months, and movement training was initiated. We noticed that both of the patient's palms had a single transverse palmar crease and that his intellectual development was significantly behind that of children of the same age; therefore, we considered the diagnosis of developmental delay and genetic mutation. Brain MRI (April 3, 2019) showed abnormal signal changes in the deep white matter area adjacent to the lateral ventricle (symmetrical distribution of patch‐like, slightly longer T1 and slightly longer T2 signal changes can be seen in the deep white matter area beside the lateral ventricles of the bilateral cerebrum, with low signal on DWI and slightly low signal on T2 FLAIR) (Figure 2). The patient's rehabilitation program has continued till date.
FIGURE 2

MRI scan of the patient's brain showed abnormal signal changes in the deep white matter area near the lateral ventricle and a mild delay of myelination compared with a healthy child at the age of 7 months

MRI scan of the patient's brain showed abnormal signal changes in the deep white matter area near the lateral ventricle and a mild delay of myelination compared with a healthy child at the age of 7 months Whole‐exome sequencing (WES) detection revealed the following: UBE2A:NM_003336.3:exon4:c.241 + 1G > A: variant: pathogenic (PVS1 + PM2 + PP3) (Figure 3). Strong evidence of pathogenicity (PVS1) was present as the mutation identified occurs in the splicing region and may lead to altered protein function. There was moderate pathogenic evidence (PM2) as the mutation is listed in the Berry gene Chinese population‐specific database “Shenzhou Genome Database” and the Human Exon Database (ExAC), but not in the Reference Population Thousand Genomes (1000G) and Population Genome Mutation Frequency Database (gnomAD). The supporting pathogenic evidence (PP3) included the following: a conservative prediction by GERP, showing that this locus is evolutionarily conserved and has the potential for functional impact, and a protein function prediction by CADD and DANN, indicating that the mutation is harmful.
FIGURE 3

Variant sequencing of the proband. (A) One nucleotide (241 + 1 G > A, in blue) near exon 4 (in red frame) was modified, likely influencing UBE2A gene splicing. UBE2A DNA (in red sequencing). (B) Schematic of the UBE2A gene, showing the position of the newly identified (in red) and previously published variants (in black). Reference sequence for the UBE2A gene: NM_003336.3

Variant sequencing of the proband. (A) One nucleotide (241 + 1 G > A, in blue) near exon 4 (in red frame) was modified, likely influencing UBE2A gene splicing. UBE2A DNA (in red sequencing). (B) Schematic of the UBE2A gene, showing the position of the newly identified (in red) and previously published variants (in black). Reference sequence for the UBE2A gene: NM_003336.3 According to a public database query, UBE2A gene mutations (OMIM:312180) can cause X‐linked recessive, X‐linked syndromic, and Nascimento‐type intellectual disability (OMIM: 300860, Budny et al. al., 2010). X‐linked intellectual disability syndrome Nascimento type mainly manifests as intellectual disability, language delay, midface dysplasia, and small feet. The results of next‐generation sequencing showed that the proband had a hemizygous UBE2A mutation (c.241 + 1G > A), the mother had a heterozygous mutation, and the father had no mutation; therefore, the mutation was inherited from the phenotypically normal mother (Figure 4A).
FIGURE 4

Sequencing and DNA analysis of the proband's family members (A) c.241 + 1 G > A. (B) No chromosomal aneuploidy or known, definite pathogenic genomic copy number variants (CNVs) greater than 100 kb were detected in this sample

Sequencing and DNA analysis of the proband's family members (A) c.241 + 1 G > A. (B) No chromosomal aneuploidy or known, definite pathogenic genomic copy number variants (CNVs) greater than 100 kb were detected in this sample The CNV‐seq test results revealed no chromosomal aneuploidy or known, definite pathogenic genomic copy number variations (CNVs) above 100 kb (Figure 4B). The family denied any similar medical history in the family and any genetic metabolism‐related family medical history. A physical examination conducted at the age of 7 months revealed that the patient's height was 62.5 cm, his head circumference was 40.0 cm, and his weight was 6.9 kg. The patient presented with a short stature, flat face, wide eye spacing, and a single transverse palmar crease. The patient's face was round, and his upper and lower limbs were short (Figure 5A–E). Cardiopulmonary auscultation showed no obvious abnormalities.
FIGURE 5

Clinical characteristics of the patient. (A) Flat face; round face; wide‐set eyes; the red arrows indicates both palms have a single transverse palmar crease

Clinical characteristics of the patient. (A) Flat face; round face; wide‐set eyes; the red arrows indicates both palms have a single transverse palmar crease A professional examination was conducted at the child health department, and the patient's mental performance was determined to be normal, his responses average, and his follow‐up and listening abilities were good. However, the patient insensitive to teasing, little active pronunciation and was prone to crying. He was unable to hold his head up for more than 15 s, was happy leaning back, held his head up at an angle less than 45°, demonstrated poor elbow support, was unable to roll over, and showed poor lower body weight support. The muscle tone of the limbs was low, and the tendon reflexes were slightly weakened. In the auxiliary examination, during the patient's hospitalization in the neonatal department, echocardiography showed patent ductus arteriosus, congenital ventricular septal defect and patent foramen ovale. A hearing test (April 3, 2019) revealed the following: 40 dnBl/50 dnBl. On April 24, 2019, re‐examination at our hospital revealed no obvious abnormality. An X‐ray of the hip joint (December 9, 2019) at our hospital showed no obvious abnormalities, and repeated thyroid function, routine blood tests, and liver and kidney function tests showed no obvious abnormalities. A Gesell test (May 18, 2020) was conducted and revealed the following: 29 points for adaptability, 30 points for gross motor, 34 points for fine motor, 46 points for language, and 47 points for personal‐social. Till date, for treatment, the child has been administered exercise training, EEG, EMG, intermediate frequency therapy, biofeedback, occupational therapy, language training, and other interventions in our department. Currently, the child is able to walk with assistance. He can walk several steps by himself but cannot squat or stand alone. After a fall, the patient moves into a sitting position and stands up with the assistance of an object. He can say common names such as mom, dad, and grandma, and he can name common items, with a vocabulary of approximately 10 words. His word comprehension is dominated by nouns, approximately 30 words. He can understand simple commands. He is able to pinch pills with his thumb and index finger, but his fingertip pinching is poor. He is able to build with 2 building blocks, uses the index finger to point to objects, and can hold a pen to doodle; however, he cannot match a shape to a board, cannot self‐feed with a spoon, and requires assistance with putting on and taking off his clothes. His limb muscle tone remains slightly low. The patient is uncooperative in muscle strength examinations, but the tendon reflexes can be elicited by Gesell's test (December 2, 2021), and the most recent findings are as follows: 35 points for adaptability, 29 points for gross motor, 28 points for fine motor, 47 points for language, and 28 points for personal‐social.

DISCUSSION

In the present study, we used whole‐exome sequencing to identify a novel UBE2A splice site variant (c.241 + 1 G > A) in a Chinese proband with X‐linked intellectual disability. This is the second case report of this syndrome associated with novel splice site variants in China, to the best of our knowledge. Notably, we report novel molecular and clinical data of this patient with intellectual disability. Till date, only two splice‐site variants in UBE2A, seven missense variants in UBE2A, and four larger deletions in UBE2A have been reported. , , , , , , , , , , In addition, all probands with UBE2A deficiency syndrome have similar phenotypes, including characteristic facial appearance, speech anomalies, and intellectual disability. , However, the clinical presentation of our proband was novel, including a deep single transverse palmar crease and an inability to hold the head erect, which has not been described in previous patients. In addition, the phenotypes of all reported probands with UBE2A variant syndrome and the patient described in the present study were analyzed, and three UBE2A variant syndrome patient groups could be classified: (1) those with larger deletions (largedel), (2) those with missense variants (miss), and (3) those with splice site variants (splice) (Table 1). All patients were males and showed severe intellectual disability and speech impairment.
TABLE 1

Clinical and molecular data of patients with UBE2A Deficiency Syndrome due to missense mutation of UBE2A (Each in a Separate Column), as well as of patients with splice site mutation (splice), each type of mutation are summarized in a separate column—larger deletions (largedel), missense mutation (miss), and splice site mutation (splice) in UBE2A

ReferencesDingyuan Ma et.al (2019)Giugliano et al. (2018)Nascimento et al.(2006)Budny et al. (2010)Haddad et al. (2013)Czeschik et al. (2013)Tsurusaki et al. (2017)Weimin Jia et al. (2019)de Leeuw et al; Honda et al; Thunstrom et al; Czeschik et al;
Patient11III.3III.812IV:4V:2IV:13III:12IV:3III‐5III‐6III‐751II:3
General
Type of mutationSpliceSpliceSpliceMissMissMissMissMissMissLargedelMissSplice
Number of different mutation473
Number of patients9134
GenderMMMMMMMMMMMMMMMMMMMM
EthnicityChineseChineseCaucasianBrazilianCaucasianCaucasianJapaneseChinese
Mutationc.241 + 1G > Ac.331‐2A > G (p.L112SfsX17)c.330G > A (p.Y82SfsX4)c.382C > Tc.67G > A (p.G23R)c.32G > A (p.R11Q)c.19C > T (p.R7W)c.236C > G (p.P79R)c.76G > A (p.G26R)c.245A > G (p.Y82C)
Gestational weeks35 + 4 WNA39403535NA3940NA39NANANA4039NA
Birth weight (g)2150NA3970315024053200NA35005500NA3600NANANA28002355NA
Birth height (cm)NANA36354850NANANANANANANANANA46NA
Development
Inability to maintain his head in upright position+NANANANANANANANANANANANANANA0/00/01/1
Speech impairment+++++++++++++++++9/913/134/4
Intellectual disability+++++++++++++++++9/913/134/4
Heart defectsNANA++NANANANANANANANA+NA9/93/40/2
White matter abnormalities++NANA+NANANANANANANA++6/73/62/2
Dysmorphic features
Synophrys++++++++++++++6/912/132/4
Ocular hypertelorism+++++NANANA+8/93/103/4
Wide face++++NANA++NANANA+NA0/03/74/4
Upslanting palpebral fissures++NANANANANA+7/93/80/4
Small feet+NA++++NA5/84/121/3
Generalized hirsutismNA+++NANA+++++++++4/910/112/3
Hearing loss/impairment+NA+NANANANANANANANANA+NANA2/82/21/3
Genital anomalities
Small penis+NA+NA++++++++NA7/98/122/2

Note: Patients with missense mutation (miss) and splice site mutation (splice) include patient 1 (described here. The patients with Larger Deletions (largedel)reported by de Leeuw et al (2010), Hoddad et al. (2010), Czeschik et al. (2013), Thunstrom et al. (2015). Each Type of Mutation are Summarized in a Separate Column—Larger Deletions (largedel), missense mutation (miss), and splice site mutation (splice), number of affected individuals with available clinical data.

Abbreviation: NA, not available.

Clinical and molecular data of patients with UBE2A Deficiency Syndrome due to missense mutation of UBE2A (Each in a Separate Column), as well as of patients with splice site mutation (splice), each type of mutation are summarized in a separate column—larger deletions (largedel), missense mutation (miss), and splice site mutation (splice) in UBE2A Note: Patients with missense mutation (miss) and splice site mutation (splice) include patient 1 (described here. The patients with Larger Deletions (largedel)reported by de Leeuw et al (2010), Hoddad et al. (2010), Czeschik et al. (2013), Thunstrom et al. (2015). Each Type of Mutation are Summarized in a Separate Column—Larger Deletions (largedel), missense mutation (miss), and splice site mutation (splice), number of affected individuals with available clinical data. Abbreviation: NA, not available. In our case, cardiac malformations were found in the fetal and neonatal period but disappeared as the patient grew older. This observation is different from that of other individuals with UBE2A variants with heart defects. , , , , , According to recent reports, four other patients did not have upslanting palpebral fissures. Although these analyses were based on a small number of patients and, therefore, it is difficult to draw valid conclusions, it is worth noting that this observation suggests that individuals with UBE2A splice site variants might not be at increased risk for upslanting palpebral fissures and heart defects. Conversely, individuals with UBE2A splice site variants might be at an increased risk for wide facies, white matter abnormalities and a small penis. In this boy, the clinical presentation of this new phenotype included shorter limbs. At a gestational age of 34 + 4 W, a four‐dimensional color Doppler ultrasound indicated that the femur and humerus were of a size expected for a fetus at a gestation age of approximately 30 W, which may be a new phenotype of UBE2A gene variants. In conclusion, this report describes novel splice site variants (c.241 + 1 G > A) in the UBE2A gene resulting in an aberrant appearance and severe intellectual disability in a Chinese proband. The patient was found to have a novel clinical appearance, including a deep single transverse palmar crease and inability to hold the head erect. Our report expands the variant spectrum and clinical characteristics of UBE2A deficiency syndrome (also called XLID) and may provide clinical evidence for genetic diagnoses.

AUTHOR CONTRIBUTIONS

Jun He, Shuyuan Yan, Yanling Wang, Ying Cheng, Hongxia Yuan, Xiaoni Kuang, Da Hou, Xueyi Li, Linglin Pan, Guangwen Huang, and Jun He involved in conceptualization, data curation, and formal analysis. Tuanmei Wang involved in funding acquisition. Xiangwen Peng performed writing—review and editing.

CONFLICTS OF INTEREST

The authors have no conflicts of interest to disclose.

ETHICAL APPROVAL

The Ethics Committee of Changsha Maternal and Child Health Hospital approved this study.

CONSENT

Written informed consent was obtained from the parent's patient to publish this report in accordance with the journal's patient consent policy because the patient is a child.
  23 in total

1.  XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing.

Authors:  Amélie Piton; Claire Redin; Jean-Louis Mandel
Journal:  Am J Hum Genet       Date:  2013-07-18       Impact factor: 11.025

2.  X-linked intellectual disability: Phenotypic expression in carrier females.

Authors:  Catherine A Ziats; Charles E Schwartz; Jozef Gecz; Marie Shaw; Michael J Field; Roger E Stevenson; Giovanni Neri
Journal:  Clin Genet       Date:  2019-11-24       Impact factor: 4.438

3.  Schimke XLID syndrome results from a deletion in BCAP31.

Authors:  Raymond J Louie; Debra L Collins; Michael J Friez; Cindy Skinner; Charles E Schwartz; Roger E Stevenson
Journal:  Am J Med Genet A       Date:  2020-07-18       Impact factor: 2.802

4.  Novel missense mutations in the ubiquitination-related gene UBE2A cause a recognizable X-linked mental retardation syndrome.

Authors:  B Budny; M Badura-Stronka; A Materna-Kiryluk; A Tzschach; M Raynaud; A Latos-Bielenska; H H Ropers
Journal:  Clin Genet       Date:  2010-04-19       Impact factor: 4.438

5.  Delineation of Clinical Manifestations of the Inherited Xq24 Microdeletion Segregating with sXCI in Mothers: Two Novel Cases with Distinct Phenotypes Ranging from UBE2A Deficiency Syndrome to Recurrent Pregnancy Loss.

Authors:  Ekaterina N Tolmacheva; Anna A Kashevarova; Lyudmila P Nazarenko; Larisa I Minaycheva; Nikolay A Skryabin; Maria E Lopatkina; Tatyana V Nikitina; Elena A Sazhenova; Elena O Belyaeva; Elizaveta A Fonova; Olga A Salyukova; Victor S Tarabykin; Igor N Lebedev
Journal:  Cytogenet Genome Res       Date:  2020-05-30       Impact factor: 1.636

Review 6.  X-linked intellectual disability update 2017.

Authors:  Giovanni Neri; Charles E Schwartz; Herbert A Lubs; Roger E Stevenson
Journal:  Am J Med Genet A       Date:  2018-04-25       Impact factor: 2.802

7.  Deficiency in the Ubiquitin Conjugating Enzyme UBE2A in Alzheimer's Disease (AD) is Linked to Deficits in a Natural Circular miRNA-7 Sponge (circRNA; ciRS-7).

Authors:  Yuhai Zhao; Peter N Alexandrov; Vivian Jaber; Walter J Lukiw
Journal:  Genes (Basel)       Date:  2016-12-05       Impact factor: 4.096

8.  A novel splice site mutation in the UBE2A gene leads to aberrant mRNA splicing in a Chinese patient with X-linked intellectual disability type Nascimento.

Authors:  Dingyuan Ma; Jianxin Tan; Jing Zhou; Jingjing Zhang; Jian Cheng; Chunyu Luo; Gang Liu; Yuguo Wang; Zhengfeng Xu
Journal:  Mol Genet Genomic Med       Date:  2019-09-30       Impact factor: 2.183

9.  The Role of the Reanalysis of Genetic Test Results in the Diagnosis of Dysmorphic Syndrome Caused by Inherited xq24 Deletion including the UBE2A and CXorf56 Genes.

Authors:  Ewelina Wolańska; Agnieszka Pollak; Małgorzata Rydzanicz; Karolina Pesz; Magdalena Kłaniewska; Anna Rozensztrauch; Paweł Skiba; Piotr Stawiński; Rafał Płoski; Robert Śmigiel
Journal:  Genes (Basel)       Date:  2021-02-27       Impact factor: 4.096

Review 10.  An intellectual disability syndrome with single-nucleotide variants in O-GlcNAc transferase.

Authors:  Veronica M Pravata; Michaela Omelková; Marios P Stavridis; Chelsea M Desbiens; Hannah M Stephen; Dirk J Lefeber; Jozef Gecz; Mehmet Gundogdu; Katrin Õunap; Shelagh Joss; Charles E Schwartz; Lance Wells; Daan M F van Aalten
Journal:  Eur J Hum Genet       Date:  2020-02-20       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.